Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Universal MRSA screening

This article was originally published in The Gray Sheet

Executive Summary

Evanston Northwestern Healthcare, a Chicago-area hospital system, decreased its methicillin-resistant Staphylococcus aureus infection rate by 69.6% (from 8.9 hospital-acquired infections per 10,000 patient-days to 3.9) in two years of implementing universal screening for MRSA in all hospital admissions, according to a recent study. Published March 18 in the Annals of Internal Medicine, the results compare favorably to a Swiss study that appeared in the Journal of the American Medical Association the previous week, showing no benefit from universal MRSA screening (1"The Gray Sheet" March 17, 2008, p. 13). Ebbing Lautenbach, University of Pennsylvania, notes in an accompanying AIM editorial that it is still premature for all hospitals to adopt universal screening, since the relative contribution of the test and concurrent interventions remains unclear. Evanston Northwestern uses BD's GeneOhm rapid molecular MRSA test

You may also be interested in...



Universal Screening For MRSA Does Not Reduce Infections – JAMA Study

Using a rapid molecular assay to screen all surgical patients on admission for a prevalent drug-resistant infection did not reduce the incidence of hospital-acquired infections in a Swiss study involving more than 20,000 patients

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities

Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel